Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
532.85
Change Change %
7.40 1.41%

Updated:21 Nov, 2018, 15:59 PM IST

BSE
531.15
Change Change %
5.65 1.08%

Updated:21 Nov, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
CLSA
N/A
02-09-2015 Buy 906.00 1088.00
N/A
Closed Custom
02-09-2016

CLSA Maintains Buy on Sun Pharma

CLSA has maintained buy on Sun Pharma for target price of Rs 1,088. CLSA sees growth in FY17 EBITDA. It expects synergy benefits of $100 million-120 million from Ranbaxy in FY17. CLSA adds that India, core US & generic Gleevec launch critical. However, delay in new approvals/no Halol resolution are key risks to Sun Pharma.

Top